Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
DIH Holdings US, Inc. Class A Common Stock (DHAI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/03/2025: DHAI (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
0 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
Analysis of Past Performance
Type Stock | Historic Profit -3.8% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 11.88M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.03 | 52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 |
52 Weeks Range 0.12 - 3.67 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -14.79% | Operating Margin (TTM) -17.49% |
Management Effectiveness
Return on Assets (TTM) -4.63% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 26684334 | Price to Sales(TTM) 0.17 |
Enterprise Value 26684334 | Price to Sales(TTM) 0.17 | ||
Enterprise Value to Revenue 0.41 | Enterprise Value to EBITDA - | Shares Outstanding 47336300 | Shares Floating 15773934 |
Shares Outstanding 47336300 | Shares Floating 15773934 | ||
Percent Insiders 50.42 | Percent Institutions 12.13 |
Upturn AI SWOT
DIH Holdings US, Inc. Class A Common Stock
Company Overview
History and Background
DIH Holdings US, Inc. is a global med-tech company that has evolved through strategic acquisitions and organic growth, focusing on rehabilitation solutions. It provides comprehensive rehabilitation technology and solutions.
Core Business Areas
- Rehabilitation Robotics: Develops and distributes robotic devices used in physical and occupational therapy to assist patients in regaining motor skills and function.
- Virtual Reality Rehabilitation: Provides virtual reality systems that simulate real-world environments, creating engaging and interactive therapy sessions for patients.
- Clinical Assessment Tools: Offers assessment tools and technologies used by clinicians to measure patient progress and customize treatment plans.
- Therapy Services: Delivers therapy services through its network of rehabilitation centers, providing direct patient care and clinical expertise.
Leadership and Structure
The leadership team includes individuals with experience in medical device technology, clinical operations, and business development. The organizational structure includes divisions for product development, sales and marketing, clinical operations, and finance.
Top Products and Market Share
Key Offerings
- Motus Nova: A rehabilitation robotic device used to help patients recover motor skills. Market share data is variable. Competitors include Hocoma, ReWalk Robotics.
- SafeGait: A gait and balance training system designed to prevent falls and improve mobility. Competitors include Biodex Medical Systems, AlterG.
- Tyromotion AMADEO: A hand rehabilitation device. Competitors include Kinestica, Saebo.
Market Dynamics
Industry Overview
The rehabilitation technology market is growing due to an aging population, increasing incidence of stroke and other neurological disorders, and advancements in robotics and virtual reality technologies.
Positioning
DIH Holdings is positioned as a provider of integrated rehabilitation solutions, combining robotic devices, virtual reality, and clinical expertise. Their competitive advantage lies in offering a comprehensive suite of products and services.
Total Addressable Market (TAM)
The global rehabilitation robotics market is expected to reach billions of dollars. DIH Holdings is positioned to capture a portion of this TAM through its diverse product portfolio.
Upturn SWOT Analysis
Strengths
- Comprehensive product portfolio
- Global presence
- Experienced management team
- Integrated solutions approach
Weaknesses
- Relatively small market share compared to some competitors
- Dependence on technological advancements
- Regulatory hurdles in some markets
- Capital intensive
Opportunities
- Expanding into new geographic markets
- Developing new products and services
- Forming strategic partnerships
- Increasing adoption of telehealth and remote monitoring
Threats
- Competition from larger companies
- Technological obsolescence
- Changes in healthcare regulations
- Economic downturn
Competitors and Market Share
Key Competitors
- Hocoma (Not a publicly traded US company)
- AlterG (Not a publicly traded US company)
- Biodex Medical Systems (Not a publicly traded US company)
- ReWalk Robotics (RWLK)
Competitive Landscape
DIH Holdings faces competition from both established medical device companies and emerging technology firms. The company's competitive advantages include its comprehensive product portfolio and global presence. Disadvantages include its relatively small market share and dependence on technological advancements.
Major Acquisitions
SafeGait
- Year: 2016
- Acquisition Price (USD millions): 26
- Strategic Rationale: To expand its product line in gait and balance training systems and enhance its market position.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are not available without specific financial data. Past performance can be inferred from revenue growth and market share changes reported in financial statements and market analyses.
Future Projections: Future growth projections require analyst estimates, which are unavailable in this format. Consult financial analysts' reports for forecasts of DIH Holdings's future growth.
Recent Initiatives: Recent initiatives might include product launches, acquisitions, strategic partnerships, and expansion into new markets. Refer to the company's press releases and investor relations materials for details.
Summary
DIH Holdings US, Inc. is a global med-tech company focused on rehabilitation technology, offering a comprehensive suite of products and services. It faces competition from larger companies but holds potential for growth through strategic initiatives. Key strengths include its diverse product portfolio and global presence, while weaknesses include its dependence on technological advancements. Monitoring market dynamics and competitor activities is crucial for sustained success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Press Releases
- Market Analysis Reports
- SEC Filings (if applicable)
Disclaimers:
The information provided is based on available public data and market analysis. Market share data is estimated and subject to change. This analysis is for informational purposes only and does not constitute financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DIH Holdings US, Inc. Class A Common Stock
Exchange NASDAQ | Headquaters Norwell, MA, United States | ||
IPO Launch date 2022-03-21 | Founder, Chairman & CEO Mr. Jason Chen | ||
Sector Healthcare | Industry Medical Devices | Full time employees - | Website https://www.dih.com |
Full time employees - | Website https://www.dih.com | ||
DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.